MHMohammad Karim Haidar

Mohammad Karim Haidar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Karim Haidar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Emirhan Nemutlu

    Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey

    3 shared publications
  • Hakan Eroglu

    Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey

    3 shared publications
  • Kezban Ulubayram

    Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Hacettepe University 06100, Ankara, Turkey

    3 shared publications
  • Levent Öner

    Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey

    3 shared publications
  • Mitsuru Hashida

    Kyoto University Graduate School of Pharmaceutical Science, Department of Drug Delivery Research, Kyoto, Japan

    2 shared publications
  • Selin Seda Timur

    Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey

    2 shared publications

Latest Publications

  • Minocycline Hydrochloride Controlled-release Microsphere Preparation Process Optimization Based on the Robust Design Method

    by Mohammad Karim Haidar, Fumiyoshi Yamashita, Mitsuru Hashida

    The objective of the present study is to establish a robust preparation method that could steadily produce minocycline hydrochloride (MCH) microspheres regardless of used polymer types. Taguchi’s Robust Experimental Design methodology was employed to optimize the process parameters for MCH-loaded poly(D,L-lactide-co-glycolide) (PLGA) microspheres. In the experimental design, seven controllable factors, i.e., preparation method, pH of the aqueous phase, volume of the aqueous phase, volume of dichloromethane, rotation speed, temperature, and amount of polyvinyl alcohol, were considered for the optimization of process parameters. PLGA types with different lactide/glycolide ratios were considered the uncontrollable (noise) factor. Based on the L18 orthogonal array, 18 experimental runs were conducted for each type of PLGA. The encapsulation efficiency (EE) and in vitro release rate were evaluated for all the prepared formulations. Regardless of the PLGA type with different lactic/glycolic acid ratios, microspheres prepared via the solid-in-oil-in-water (S/O/W) method, showed a much higher EE and faster drug release than the microspheres prepared via the co-solvent method. Preparation methods, pH of the aqueous phase, and volume of the aqueous phase were the most influencing parameters on the EE. The confirmation experiment results indicated that the signal-to-noise ratio increased by 5.76 db from that of an initial condition. The release of minocycline was fastest with the PLGA (50:50) microspheres, followed by PLGA (75:25) and PLGA (85:15). Although the interaction between the selected factors in the evaluation was ignored, the orthogonal array design of the experiment based on Taguchi’s robust experimental design methodology was sufficient to optimize the process parameters for the PLGA microspheres of MCH. The S/O/W was the main factor affecting the EE. Microspheres prepared via the S/O/W method exhibited a higher EE and faster drug release than the microspheres prepared via co-solvent method. The pH and volume of the aqueous phase were also effective parameters on the EE. A robust experimental design has been successfully applied to the optimization of the process parameters for microsphere preparation.


  • Composite nanofibers incorporating alpha lipoic acid and atorvastatin provide neuroprotection after peripheral nerve injury in rats

    by Mohammad Karim Haidar, Selin Seda Timur, Atilla Kazanci, Omer Faruk Turkoglu, R. Neslihan Gürsoy, Emirhan Nemutlu, Mustafa Fevzi Sargon, Ebru Bodur, Müslüm Gök, Kezban Ulubayram, et al.


  • Atorvastatin-loaded nanosprayed chitosan nanoparticles for peripheral nerve injury

    by Mohammad Karim Haidar, Gülen Melike Demirbolat, Selin Seda Timur, Reyhan Neslihan Gürsoy, Emirhan Nemutlu, Kezban Ulubayram, Levent Öner, Hakan Eroğlu

    In this study, chitosan nanoparticles containing atorvastatin calcium were prepared using the nanospray-drying method to be used in the local treatment of peripheral nerve injuries. The main focus was to investigate the effect of the molecular weight and concentration of the polymer, the concentration of the active pharmaceutical ingredient and the diameter of the spray nozzle (4·0, 5·5 and 7·0 μm) on the final properties of nanoparticles. Atorvastatin nanoparticles were characterized in terms of morphology, particle size, polydispersity index (PDI), zeta potential, encapsulation efficiency and in vitro release. In all formulations, the nanoparticles were found to be in the submicrometer range (510·5 ± 22·3–820·0 ± 98·7 nm) with a positive surface charge (11·1–26·6 mV) and a narrow particle size distribution (PDI = 0·10–0·58). Further evaluation of the synthesized nanoparticles revealed high encapsulation efficiency (23·37–53·61%) and production yield (58·30–74·10%). Critical examination of the morphology of nanoparticles in all formulations indicated that the nanoparticles were almost spherical in shape and had a wrinkled surface. The in vitro release test revealed that the nanoparticles were capable of maintaining a sustained release of atorvastatin for about 200 h. The cytotoxicity of chitosan nanoparticles was evaluated using L-929 and B35 cells, and the nanoparticles were found to show no toxic effect.


  • Dual release behavior of atorvastatin and alpha-lipoic acid from PLGA microspheres for the combination therapy in peripheral nerve injury

    by Hakan Eroğlu, Mohammad Karim Haidar, Emirhan Nemutlu, Şükrü Öztürk, Cem Bayram, Kezban Ulubayram, Levent Öner


  • Nanofibers: New Insights for Drug Delivery and Tissue Engineering

    by Mohammad Haidar, Hakan Eroglu

    Nanofibers became one of the major research areas for drug delivery and tissue engineering applications in the last decade. Depending on the simplicity of the preparation method and high drug loading capacity, nanofibers provide many advantages for therapeutic perspectives. In addition, combined systems such as embedding nanoparticles into the nanofiber structures provide a second option for delivery of dual active ingredients in the same formulation. The release rate of the active ingredients can also be modified easily by the formulation parameters depending on the desired release time for treatment. Nanofibers systems are used for the delivery of antibiotics, anticancer drugs, analgesics, hemostatic agents and various proteins for tissue engineering purposes. In addition, various applications such as medical device coating also provide new insights for the clinical use of nanofibers. The most commonly used technique for preparation of nanofibers is the electrospinning, which provides feasibility background for scale up process from laboratory to the industrial applications. The main boundary for nanofibers is the limitations for systemic route. Nanofibers are mainly designed for the delivery of active ingredients for local purposes. Regardless of the therapeutic aim, nanofibers are also perfect 3 dimensional structures that are suitable for tissue regeneration. They provide matrix structure for cell regeneration especially in applications for wound healing. This review is mainly focused on the recent advances on the preparation of nanofibers, applications for drug delivery, tissue engineering and wound healing purposes.


  • A novel multi-dimensional visualization technique for understanding the design parameters of drug formulations

    by Fumiyoshi Yamashita, Takayuki Itoh, Shuya Yoshida, Mohammad K. Haidar, Mitsuru Hashida